Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Understand the benefits of no fee cash back credit cards. Save money while enjoying rewards for your purchases.
25,488 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Two very different paths define the nuclear renaissance: NuScale's small modular reactors and BWX Technologies' broad...
Public disclosures can spark headlines, but the real value for everyday investors lies in interpretation. Learn how t...
A major stake sale can ripple through markets and portfolios. This article breaks down what arena capital sells milli...
IMAX stock jumped this week as takeover chatter surfaced. This article breaks down the drivers behind the move, what ...
Investors scanned the markets as AMC faced dilution concerns that weighed on sentiment. This piece breaks down what h...
Mesirow Financial Investment Management revealed a substantial new holding in the Akre Focus ETF. This piece explains...
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
At age 65, Health Savings Accounts shift from a pure medical fund to a hybrid tool that can rival a 401(k) for non-me...
Sprinklr has seen a steep slide, slipping about 40% over the past year. A large fund recently sold close to $3 millio...
When a founder makes a bold move after a price drop, investors sit up and take notice. This article unpacks what a pu...
In the first half of 2026, silver moved in two dramatic acts: a rapid ascent followed by a sharp pullback. This artic...